DAX19.323 +0,9%ESt504.789 +0,7%MSCIW3.766 +0,3%Dow44.297 +1,0%Nas19.004 +0,2%Bitcoin94.712 -0,3%Euro1,0417 -0,6%Öl75,28 +1,2%Gold2.709 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 MicroStrategy 722713 Tesla A1CX3T Rheinmetall 703000 Bayer BAY001 Siemens Energy ENER6Y EVOTEC 566480 Volkswagen (VW) vz. 766403 Amazon 906866 Deutsche Telekom 555750 NEL ASA A0B733 Mercedes-Benz Group (ex Daimler) 710000 Coinbase A2QP7J Deutsche Bank 514000 Palantir A2QA4J
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht deutlich fester ins Wochenende -- US-Börsen schließen höher -- Bitcoin knapp vor 100.000 US-Dollar -- Chef der US-Börsenaufsicht tritt ab -- RWE, Secunet, NEL im Fokus
Top News
KW 47: Tops und Flops der TecDAX-Aktien in der vergangenen Woche KW 47: Tops und Flops der TecDAX-Aktien in der vergangenen Woche
KW 47: Goldpreis, Ölpreis & Co. - So performten Rohstoffe in der vergangenen Woche KW 47: Goldpreis, Ölpreis & Co. - So performten Rohstoffe in der vergangenen Woche
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Homology Medicines Aktie

NeuKaufenVerkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

WKNA2JGTY

ISINUS4380831077

SymbolFIXX

Homology Medicines Aktien News

DatumMeistgelesen
PR NewswireHOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
PR NewswireQ32 Bio and Homology Medicines Announce Merger Agreement
finanzen.netHomology Medicines mit Zahlen zum abgelaufenen Quartal
PR NewswireSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Homology Medicines, Inc. (NASDAQ: FIXX) and Encourages Long-Term Investors to Contact the Firm - FIXX
finanzen.netHomology Medicines: Was beim Unternehmen in den jüngsten Büchern steht
finanzen.netHomology Medicines legte die Bilanz zum abgelaufenen Quartal vor
finanzen.netHomology Medicines mit Zahlen zum abgelaufenen Quartal
finanzen.netHomology Medicines: Das sind die jüngsten Quartalszahlen
finanzen.netHomology Medicines gab Ergebnis zum abgelaufenen Quartal bekannt
PR NewswireSHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXX
PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Homology Investors of a Lead Plaintiff Deadline of May 24, 2022
finanzen.netHomology Medicines legte die Bilanz zum abgelaufenen Quartal vor
PR NewswireROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXX
PR NewswireROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 24, 2022 - (NASDAQ: FIXX)
PR NewswireFIXX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 24, 2022 in the Class Action Filed on Behalf of Homology Medicines, Inc. Shareholders
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXX
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 24, 2022 - (NASDAQ: FIXX)
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Homology Medicines, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of May 24, 2022 - (NASDAQ: FIXX)
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXX
PR NewswireFIXX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 24, 2022 in the Class Action Filed on Behalf of Homology Medicines, Inc. Shareholders
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Homology Medicines, Inc., of Class Action Lawsuit and Upcoming Deadline - FIXX
PR NewswireSHAREHOLDER NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXX
PR NewswireBronstein, Gewirtz & Grossman, LLC Notifies Homology Medicines, Inc. (FIXX) Shareholders of Class Action and Encourages Investors to Contact the Firm
PR NewswirePomerantz Law Firm Announces the Filing of a Class Action Against Homology Medicines, Inc., and Certain Officers - FIXX
finanzen.netHomology Medicines: Quartalsergebnisse zum jüngsten Jahresviertel
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Homology Medicines, Inc. - FIXX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Homology Medicines, Inc. - FIXX

Homology Medicines News

Homology Medicines News: auf dieser Seite finden Sie alle Homology Medicines News und Nachrichten zur Homology Medicines Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Homology Medicines News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Homology Medicines News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.